IGF-1 DES vs MK-677 — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
IGF-1 DES (des(1-3)IGF-1) is a naturally occurring truncated form of IGF-1, produced endogenously in the brain and other tissues, that lacks the first three N-terminal amino acids (Gly-Pro-Glu) of full-length IGF-1. This truncation eliminates its binding to IGF-binding proteins (...
Calculate IGF-1 DES dose →MK-677 (ibutamoren) is an orally active, non-peptide ghrelin receptor agonist (GHS-R1a) that stimulates GH release from the pituitary without requiring injection. It was developed by Merck and advanced through Phase II trials for growth hormone deficiency, muscle wasting, and fra...
Calculate MK-677 dose →| Parameter | IGF-1 DES | MK-677 |
|---|---|---|
| Category | Growth Hormone & IGF | Growth Hormone & IGF |
| Research | Research Use | Phase II (Discontinued) |
| Half-Life | 20–30 minutes (shorter than IGF-1 LR3) | ~24 hours |
| Typical Dose | 50–100 µg | 10–25 mg |
| Frequency | 1–2x daily (peri-workout) | Once daily |
| Route | Subcutaneous / Intramuscular (local) | Oral |
| FDA Status | Not Approved | Not Approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.